Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value, with the stock price down by -0.95% to the previous day’s close as strong demand from buyers drove the stock to $15.71. Actively observing the price movement in the last trading, the stock closed the session
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price closed higher on Monday, April 07, and jumping 13.81% above its previous close. A look at the daily price movement shows that the last close reads $15.64, with intraday deals fluctuated between $14.21 and $18.25. The company’s 5Y monthly
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $17.45 at close of the session on Tuesday, April 01 and made a downward move of -2.38% on its previous day’s price. Looking at the stock we see that its previous close was $17.88 and the beta (5Y
The trading price of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) closed lower on Tuesday, March 25, and closing at $29.77, -2.43% lower than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $27.04 and $31.5. In examining
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price on current trading day, fall -19.78% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $16.47. A look at the stock’s price movement, the close in the last trading session was $20.53,
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $13.02 at close of the session on Friday, March 07 and made a downward move of -11.00% on its previous day’s price. Tonix Pharmaceuticals Holding Corp has a market cap of $72.79 million and is expected to release
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value, with the stock price up by 40.51% to the previous day’s close as strong demand from buyers drove the stock to $10.96. Actively observing the price movement in the last trading, the stock closed the session
Today we peer into the world of biotech stocks! This is a space that is often overlooked by investors for being too high-risk, but experts realize that this industry is much more than getting a good candidate through clinical trials. In recent years, biotechnology has
As with the rest of the economy, the turmoil of Covid-19 has also affected blue-chip stocks and stocks under $1. As new strains of the disease are spreading, it is clear that the pandemic has not yet been eradicated globally. This has led to more
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
